The FDA will meet to consider easing restrictions on several peptides, a group of unapproved drugs popular with followers of Robert F. Kennedy Jr. One panel member is Bobby Harshbarger, a Tennessee state senator who has multiple connections to the industry.
Nashville's local news and NPR station
On Air - 90.3 WPLN-FM